Elicio Therapeutics ELTX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 7.96 | 119.79 | -0.49 | -8,842 | -8 | |
| 2025Q3 | 10.94 | 83.31 | -0.59 | -8,045 | -10 | |
| 2025Q2 | 7.72 | 97.34 | -0.63 | -10,091 | -11 | |
| 2025Q1 | 6.16 | 97.31 | -0.87 | -10,736 | -11 | |
| 2024Q4 | 5.10 | 97.86 | -1.02 | -13,476 | -14 | |
| 2024Q3 | 5.03 | 55.31 | -1.46 | -10,345 | -19 | |
| 2024Q2 | 4.11 | 152.14 | -0.62 | -10,924 | -7 | |
| 2024Q1 | 7.60 | 86.85 | -1.15 | -10,241 | -12 | |
| 2023Q4 | 8.34 | 104.97 | -0.21 | -9,392 | -9 | |
| 2023Q3 | 8.45 | 101.05 | 2.90 | -10,771 | -11 | |
| 2023Q2 | 9.50 | 113.65 | 15.12 | -7,777 | -8 | |
| 2023Q1 | 5.80 | 101.54 | -24.77 | -4,607 | -5 | |
| 2022Q4 | 8.12 | 100.64 | -20.75 | -21,849 | -17 | |
| 2022Q3 | 9.20 | 97.97 | -22.67 | -20,568 | -18 | |
| 2022Q2 | 11.40 | 95.95 | -3.00 | -9,035 | -9 |